Skip to main navigation Skip to search Skip to main content

Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis

Sterghios Moschos

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Abstract

    The 2013-2015 Ebolavirus disease humanitarian crisis has spurred the development of laboratory-free, point-of-care nucleic acid testing solutions. EbolaCheck is an international consortium of public health, academic and biotechnology industry stakeholders aiming to deliver clinical molecular diagnostic standard-of-care testing suitable for the West African milieu within 12 months. In this article, the current status of the EbolaCheck platform is discussed in the context of the current regulatory framework. Presented here are future goals to achieve differential diagnosis of hemorrhagic fever disease from
    Original languageEnglish
    Pages (from-to)1237-40
    JournalExpert Review of Molecular Diagnostics
    Volume15
    Issue number10
    DOIs
    Publication statusPublished - 31 Aug 2015

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis'. Together they form a unique fingerprint.

    Cite this